in the therapeutic studies which included only patients with pathogens susceptible to the antimicrobial agent used , the following cure rates ( clinical and bacteriological ) were obtained for uncomplicated infections of the lower urinary tract : ofloxacin ( single dose treatment ) 78 % and 83 % , co-trimoxazole 62 % , nalidixic acid 72 % .
C1136254
antimicrobial agent
C0028902
ofloxacin